I always appreciate these calls as they are very r
Post# of 148168
(Total Views: 707)
Posted On: 05/13/2020 4:01:35 PM
I always appreciate these calls as they are very rich on valuable information (in spite of technical difficulties and host shortcomings).
Main take-home points in (my) order of importance:
1) We have 45 patients and 6 sites are enrolling. This mean we are making very good progress and are short only 30 for data analysis. With only one patient per day per center this mean 5 days only; let’s assume we will be fully enrolled in 10 days or so, it’s likely looking before end of month for enrollment completion.
2) The up listing to NYSE seems to be in the works. Needless to say, this is huge. Nader mentioned it in a very casual way, however they are working on it together with a bank-financing deal. If, when news are released the impact on the SP will be substantial.
3) The Mexico trials are really good news. Why ?? They will provide a comparison with Remdesivir, we all know how this is going to end up. but, more importantly, more data and more results can only be positive for CYDY (hopefully less possibility of BP "tainting"
.
4) There is international scientific validation for Leronlimab MoA. There are papers being published all over the world. This is one of our main assets as one thing is to say this works and another to say why it works. I was glad to learn that Dr. Patterson was aware of the German research that is concluding the same about CCR5 and that the “unbelievable” amount of data gathered from COVID translates to cancer and the measurements of granzyme showing that CDT-8 cells are able to do their job.
Last, I liked Dr. Patterson words: “To put this country back to its feet we need a drug like Leronlimab“.
I very good conference full of direction and pivotal dates approaching. I can't believe that we are a couple of weeks or so from finishing the first trial and heralding the results for the whole world to wake up !!!
Main take-home points in (my) order of importance:
1) We have 45 patients and 6 sites are enrolling. This mean we are making very good progress and are short only 30 for data analysis. With only one patient per day per center this mean 5 days only; let’s assume we will be fully enrolled in 10 days or so, it’s likely looking before end of month for enrollment completion.
2) The up listing to NYSE seems to be in the works. Needless to say, this is huge. Nader mentioned it in a very casual way, however they are working on it together with a bank-financing deal. If, when news are released the impact on the SP will be substantial.
3) The Mexico trials are really good news. Why ?? They will provide a comparison with Remdesivir, we all know how this is going to end up. but, more importantly, more data and more results can only be positive for CYDY (hopefully less possibility of BP "tainting"
. 4) There is international scientific validation for Leronlimab MoA. There are papers being published all over the world. This is one of our main assets as one thing is to say this works and another to say why it works. I was glad to learn that Dr. Patterson was aware of the German research that is concluding the same about CCR5 and that the “unbelievable” amount of data gathered from COVID translates to cancer and the measurements of granzyme showing that CDT-8 cells are able to do their job.
Last, I liked Dr. Patterson words: “To put this country back to its feet we need a drug like Leronlimab“.
I very good conference full of direction and pivotal dates approaching. I can't believe that we are a couple of weeks or so from finishing the first trial and heralding the results for the whole world to wake up !!!
(23)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼